A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

The emergence of GLP-1 medications in recent years has presented a promising option for many people who are struggling with weight management. With celebrity promotions and advertisements dominating ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.